Falsified Medicines Directive 2011/62/EU Released

On the 9th February 2019 deadline, all manufacturers supplying pharmaceutical products to European countries will have to comply with the requirements set out in the Falsified Medicines Directive 2011/62/EU directive. 

Especially the adherence to safety features like how medicine authenticity should be verified and by whom are part of the directive which was adopted on 2nd October 2015. It was published, after scrutiny by the European Parliament and the Council, on 9th February 2016. Pharmaceutical manufacturers and Contract Manufacturing Organisations (CMOs) that need to comply with the FMD should start right now if their production sites will be compliant for this 9th February 2019 deadline.

Read the Directive for compliance here:  http://ec.europa.eu/health/sites/health/files/files/eudralex/vol-1/dir_2...

Share This